The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management

Overview of attention for article published in Cardiovascular Diabetology, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 116 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 33,986 followers.

RT @DiscoStew66: SGLT2 inhibitors: Increase LDL Increase HDL Decrease triglycerides Reduce blood pressure Reduce weight Reduce HbA1C L…

14 Aug 2022

Reply Repost Favourite

RT @DiscoStew66: SGLT2 inhibitors: Increase LDL Increase HDL Decrease triglycerides Reduce blood pressure Reduce weight Reduce HbA1C L…

14 Aug 2022

Reply Repost Favourite

SGLT2 inhibitors: Increase LDL Increase HDL Decrease triglycerides Reduce blood pressure Reduce weight Reduce HbA1C Low carb diets: See above list https://t.co/6rx0CSwQ3i

13 Aug 2022

Reply Repost Favourite

Something…something…something…low carb diets are dangerous because they raise LDL…something…something…something… “The effect of SGLT2 inhibitor on blood lipids is manifested as the increase of LDL” https://t.co/6rx0CSwQ3i

02 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.